Gleason Score 6 Prostate Carcinoma and Presence of Pathological Stage T3 Disease

被引：0
|
作者：
Razmaria, A. A. [1 ]
Negron, E. [1 ]
Zagaja, G. P. [1 ]
Shalhav, A. L. [1 ]
Eggener, S. E. [1 ]
Paner, G. P. [1 ]
机构：
[1] Univ Chicago, Chicago, IL 60637 USA
来源：
LABORATORY INVESTIGATION | 2014年 / 94卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1047
引用
收藏
页码：254A / 254A
页数：1
相关论文
共 50 条
  • [1] Gleason Score 6 Prostate Carcinoma and Presence of Pathological Stage T3 Disease
    Razmaria, A. A.
    Negron, E.
    Zagaja, G. P.
    Shalhav, A. L.
    Eggener, S. E.
    Paner, G. P.
    MODERN PATHOLOGY, 2014, 27 : 254A - 254A
  • [2] GLEASON SCORE 6 PROSTATE CANCER AND PRESENCE OF PATHOLOGICAL STAGE T3 DISEASE
    Razmaria, Aria A.
    Negron, Edris
    Shalhav, Arieh L.
    McGuire, Michael
    Zagaja, Gregory P.
    Eggener, Scott E.
    Paner, Gladell P.
    JOURNAL OF UROLOGY, 2014, 191 (04): : E471 - E472
  • [3] GLEASON 6, STAGE T3 PROSTATE CANCER IS ASSOCIATED WITH LOW RATES OF RECURRENCE
    Wiener, Scott
    Haddock, Peter
    Staff, Ilene
    Cusano, Joseph
    Wagner, Joseph
    JOURNAL OF UROLOGY, 2016, 195 (04): : E1035 - E1036
  • [4] Testosterone as a prospective predictor of pathological Gleason score and pathological stage in prostate cancer
    Drobkova, Henrieta
    Jurecekova, Jana
    Grendar, Marian
    Kliment, Jan, Jr.
    Halasova, Erika
    Kliment, Jan
    GENERAL PHYSIOLOGY AND BIOPHYSICS, 2017, 36 (05) : 549 - 556
  • [5] A comparison of the Gleason score and clinical stage preoperatively with the Gleason score and pathological stage postoperatively in patients with relapsed prostate cancer
    Kechagioglou, P.
    Ioannidou, G.
    Georgakopoulos, I.
    Alexopoulou, E.
    Katsilieris, I.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2009, 185 : 112 - 112
  • [6] Radical prostatectomy and postoperative irradiation in patients with pathological stage C (T3) carcinoma of the prostate
    Petrovich, Z
    Lieskovsky, G
    Langholz, B
    Formenti, S
    Baert, L
    Streeter, O
    Skinner, DG
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1998, 40 (01): : 139 - 147
  • [7] Clinical outcomes of high risk prostate adenocarcinoma (T3 and Gleason score ≥8)
    Sunay, M.
    Emir, L.
    Karabulut, A.
    Dadali, M.
    Erol, D.
    EUROPEAN UROLOGY SUPPLEMENTS, 2009, 8 (08) : 637 - 637
  • [8] Endorectal magnetic resonance imaging for predicting pathologic T3 disease in Gleason score 7 prostate cancer: Implications for prostate brachytherapy
    Pugh, Thomas J.
    Frank, Steven J.
    Achim, Mary
    Kuban, Deborah A.
    Lee, Andrew K.
    Hoffman, Karen E.
    McGuire, Sean E.
    Swanson, David A.
    Kudchadker, Rajat
    Davis, John W.
    BRACHYTHERAPY, 2013, 12 (03) : 204 - 209
  • [9] Occurrence of pathologic stage T3 disease at radical prostatectomy with isup grade group 1 (Gleason 3+3=6) prostate cancer.
    Greenwald, David Theodore
    Wang, Alice Y.
    Huang, Jason
    Wadhwa, Harpreet
    Nimeh, Tony
    Cohen, Justin J.
    Yonover, Paul
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [10] Commentary on "Endorectal magnetic resonance imaging for predicting pathologic T3 disease in Gleason score 7 prostate cancer: Implications for prostate brachytherapy"
    Wallner, Kent E.
    BRACHYTHERAPY, 2013, 12 (03) : 202 - 202
12345